Kaposi's sarcoma-associated herpesvirus (KSHV) causes Kaposi's sarcoma 1,2 , a cancer that commonly affects patients with AIDS 3 and which is endemic in sub-Saharan Africa 4 . The KSHV capsid is highly pressurized by its double-stranded DNA genome, as are the capsids of the eight other human herpesviruses 5 . Capsid assembly and genome packaging of herpesviruses are prone to interruption 6-9 and can therefore be targeted for the structure-guided development of antiviral agents. However, herpesvirus capsids-comprising nearly 3,000 proteins and over 1,300 Å in diameter-present a formidable challenge to atomic structure determination 10 and functional mapping of molecular interactions. Here we report a 4.2 Å resolution structure of the KSHV capsid, determined by electron-counting cryo-electron microscopy, and its atomic model, which contains 46 unique conformers of the major capsid protein (MCP), the smallest capsid protein (SCP) and the triplex proteins Tri1 and Tri2. Our structure and mutagenesis results reveal a groove in the upper domain of the MCP that contains hydrophobic residues that interact with the SCP, which in turn crosslinks with neighbouring MCPs in the same hexon to stabilize the capsid. Multiple levels of MCP-MCP interaction-including six sets of stacked hairpins lining the hexon channel, disulfide bonds across channel and buttress domains in neighbouring MCPs, and an interaction network forged by the N-lasso domain and secured by the dimerization domain-define a robust capsid that is resistant to the pressure exerted by the enclosed genome. The triplexes, each composed of two Tri2 molecules and a Tri1 molecule, anchor to the capsid floor via a Tri1 N-anchor to plug holes in the MCP network and rivet the capsid floor. These essential roles of the MCP N-lasso and Tri1 N-anchor are verified by serialtruncation mutageneses. Our proof-of-concept demonstration of the use of polypeptides that mimic the smallest capsid protein to inhibit KSHV lytic replication highlights the potential for exploiting the interaction hotspots revealed in our atomic structure to develop antiviral agents.
. The structures of MCPud from KSHV and HSV-1 are similar 21 , as are the interactions between neighbouring MCPuds mediated by the 'major helix' (yellow in Fig. 2b ). However, a loop (amino acids 767-781) in the HSV-1 MCPud is replaced by a helix (amino acids 763-778, cyan in Extended Data Fig. 5a ) in KSHV MCP, which produces a groove into which an SCP binds. Our atomic model of SCP consists of an N-terminal loop, two short helices, a stem helix and a bridging helix, and is folded like the treble clef symbol (Fig. 1d) . The stem helix binds the groove of one MCP and, in hexons, the bridging helix crosslinks to a neighbouring MCP (Fig. 2b, c) . Our previous SCP-deletion mutagenesis of KSHV demonstrated the role of SCP crosslinking in the production of virions that contain DNA 8 . Although there is no SCP bound to penton MCP in HSV-1 (ref. 22) , we clearly observed an SCP bound to each penton MCP in KSHV, albeit without crosslinking. Our model indicates that MCP-SCP interactions involve a series of hydrophobic residues (such as Tyr774, Val839, Phe840 and Leu883) on MCP. In particular, Phe840 of MCP inserts into a hydrophobic pocket formed by Leu15, Leu24, Val25, Leu49, Leu52 and Ile53 of SCP; Tyr774 of MCP has an aromatic-aromatic interaction (π -stacking) with Phe51 of SCP (Extended Data Fig. 5a ). Using co-immunoprecipitation, we investigated point mutations expressed in the KSHV MCPud (amino acids 478-1,033) that replaced these hydrophobic residues with hydrophilic residues; this abolished in vitro MCP-SCP interactions. However, in three other residues that are not in close proximity to SCP, the same type of point mutations did not affect MCP-SCP binding (Extended Data Fig. 5b ). This corroboration of our structural and functional data establishes the key residues involved in MCP-SCP binding that can be targeted for intervention ( Fig. 2d-f) .
The MCP buttress domain provides a vertical architectural support for the MCPud and a horizontal architectural support for the MCP channel domain that constricts the capsomer channel (Fig. 2a) . The buttress domain features a four-stranded β -sheet and a helix-rich periphery (Fig. 2g, h ). The channel domain fashions a six-stranded β -sheet, which is flanked by three channel-lining hairpins and by a three-helix arm that latches onto the buttress domain (Fig. 2h, i) . Within each MCP, the β -sheets from the buttress and the channel domains form a β -sandwich (Fig. 2h) . Across adjacent MCPs in a hexon, the six-stranded β -sheet of one channel domain is augmented by a β -strand from a channel domain Letter reSeArCH of an adjacent MCP; this β -strand is also connected via a loop to the six-stranded β -sheet of this adjacent MCP. In this way, six β -sheets are joined together to form a turbine-shaped ring in each hexon, and their connecting loops constrict the hexon channel to 14 Å in diameter (Fig. 2i ). Because two of the three channel-lining hairpins point inwards, if the pressurized DNA genome should ever reach and propel these hairpins, any hinged outward movement of these hairpins would produce a more constricted channel and thus prevent DNA leakage (Fig. 2h, inset) . Six disulfide bonds formed between Cys443 and Cys1231 across neighbouring MCPs (Fig. 2i, inset) further secure the wall of the hexon channel.
When the tower region of penton MCP is superposed with that of hexon MCP, its floor region is tilted approximately 15° towards the capsid centre (Extended Data Fig. 6a , Supplementary Video 3), which is consistent with the more angular geometry of the capsid at five-fold vertices. This hinged movement narrows the penton channel to 5 Å in diameter at the floor level, in contrast to 25 Å at the corresponding position in hexon channel (Extended Data Fig. 6b-d) , and separates neighbouring penton MCP tower regions from one another, producing the 'blossoming' shape and flexible nature of the penton tower.
Notwithstanding extensive interactions in the MCP tower, three types of network interactions in the MCP floor are the defining features that give rise to the mechanical sturdiness of the KSHV capsid ( Fig. 3a-f , Supplementary Videos 4, 5, Extended Data Fig. 7 ). The type I interaction is intracapsomeric β -augmentation between adjacent MCPs, as exemplified by P2 and P3 MCPs in Fig. 3c : two β -strands in the N-arm of P2 join two β -strands in the E-loop and one β -strand in the dimerization domain of P3 to form a five-stranded β -sheet. Type II and type III interactions are intercapsomeric interactions among two pairs of MCPs, such as P2-P3 and C5-C6 in Fig. 3d . To form a type III interaction, the N-lasso of C5 extends and lashes around the P2 N-arm and P3 E-loop (Fig. 3c, f) , which are participants in a type I interaction. In addition, the C5 N-lasso contributes two β -strands to augment the existing five-stranded β -sheet from the type I interaction of P2 and P3, which produces a seven-stranded β -sheet (Fig. 3c) . In this regard, type III interactions build upon and probably strengthen type I interactions. Finally, the short helix in the C5 N-lasso has hydrogen-bond interactions with the P3 helix-hairpin domain and an elbow-like helix-turn-helix structure in the P3 buttress domain, which further secures the C5 N-lasso in place. In turn, this C5 N-lasso serves as a fulcrum for the P3 elbow-like helix-turn-helix structure to support the P3 MCP tower (Fig. 3c) . Related by the local two-fold axis, another type III interaction is formed by the P2 N-lasso that lashes around the C5 N-arm and C6 E-loop (Fig. 3f) . A type II interaction is formed by two helices from each dimerization domain of P3 or C6 MCP that pair with one another around the local two-fold axis with hydrophobic residues (Fig. 3e) . From inside the capsid, this type II interaction appears to act as a pair of 'snap buttons' that sit atop the C5 and P2 N-lassoes, prevent their N termini from unwinding and thus lock them in position (Fig. 3d) . Therefore, each type II interaction also secures a pair of type III interactions. One can imagine that the force exerted by the DNA genome on the dimerization domains would make the underlying N-lassoes more resistant to unwinding.
As with other herpesviruses 23, 24 , in KSHV the network interactions that surround pentons are different from those of hexons (Fig. 3g, h,  Supplementary Video 3) . First, the penton MCP has an N terminus that is flexible, rather than one that lashes around the P1-P6 hexon MCP pair as occurs in a canonical type III interaction (Fig. 3g, h ). The N-lasso of P6 MCP, which is supposed to lash a pair of penton MCPs, also refolds into a conformation that effectively eliminates its lassoing ability (Fig. 3g) . Therefore, a penton neither lashes nor is lashed by adjacent hexons. Second, the dimerization domain of penton MCP adopts a configuration that makes it unable to form type II interactions with the dimerization domain of P1 hexon MCP (Fig. 3h) , which renders the P1 dimerization domain flexible. Instead, the refolded dimerization domain of penton MCP contributes one β -strand and the refolded N-lasso of P6 MCP contributes two β -strands-that join the N-arm and E-loop of two penton MCPs-to form a six-stranded β -sheet. This effectively glues the penton together with its surrounding P-hexons (Fig. 3g, h) . Finally, the penton MCP has a long straight helix Ta  Tb  Tc  Td  Te  SCP   Tri1   Tri2A Tri2B  P1   P2  P3  P4   P5   P6   C1  C2  C3  C4   C5   C6  E1   E2  E3   Ta   Te   Tb   Tc   Td   Tf   Penton Letter reSeArCH in its buttress domain (Fig. 3g ) that is refolded from the elbow-like helix-turn-helix structure in hexon MCP (pink in Fig. 2g ). This conformational change enables the helix to regain contact with the floor to 'buttress' the penton MCP tower without the P6 N-lasso serving as a fulcrum (Fig. 3c, g ).
Of the three types of network interaction, type III-the lashing interaction by the N-lasso-is probably the most important. To investigate its role, we mutated the 60 residues of the N terminal of MCP that encompass the N-lasso and observed the consequences in both viral lytic replication and capsid formation (Fig. 3i-l , Extended Data Fig. 8a, c, e) . Removing eight residues from the N terminus of MCP, which retains the N-lasso structure, did not affect viral propagation. By contrast, removing 16 residues from the N terminus of MCP, which renders the N-lasso incomplete, produced a 98.7% decrease in viral titre. Removing 32, 40 or 60 residues, which completely abolishes the N-lasso, reduced virion production to undetectable levels (Fig. 3i, j) . Moreover, removing 40 residues of the N terminal (MCPΔ N40) completely abolished capsid assembly (Fig. 3k, l) . Together with the above structural analyses, these results establish that the N-lasso of MCP is essential for capsid assembly.
The interaction network of the MCP floor is perforated with holes in the canyons among the towering capsomers, at local or icosahedral three-fold axes. These holes are plugged by triplexes (Fig. 4a, b) . Each triplex is a heterotrimer of a Tri1 and two conformers of Tri2-Tri2A and Tri2B (Fig. 4c-f, Supplementary Video 6) . Each Tri2 monomer has a β -sheet-rich trunk domain (amino acids 2-141, 283-305) and a helix-rich 'embracing' arm domain (142-282). Tri2A and Tri2B embrace one another to form a dimer (Fig. 4i) , which is accommodated by conformational changes in their embracing arm domains (Fig. 4g, Supplementary Video 7) . This embracing interaction involves large patches of hydrophobic residues (Extended Data Fig. 9a-d) and two disulfide bonds that are formed between Cys212 of one conformer and Cys222 of the other (Fig. 4i) . Supporting the embracing Tri2A-Tri2B dimer is the 'third-wheel' domain of the Tri1 monomer, which is structurally similar to the trunk domain of Tri2 (Fig. 4h) . The N-terminal region of Tri1 penetrates the capsid floor and folds into a tripod-shaped daisy-chain of helices (the N-anchor) that binds to three hydrophobic grooves formed by the spine helix and its associated β -sheet in the Johnson-fold domains of three adjacent MCPs (Fig. 4j, Extended Data Fig. 9e-g ). Thus, the N-anchor of Tri1 anchors the entire triplex to the capsid floor; this plugs the hole in the MCP floor and rivets the capsid shell in place. The N-anchor of Tri1 in peripentonal triplex Ta refolds in the middle arm of the tripod to accommodate the binding of a helix from the refolded dimerization domain of a penton MCP, and thus probably stabilizes the penton region (Extended Data Fig. 10) .
To investigate the function of the Tri1 N-anchor, we carried out serial-truncation mutageneses of the 65 residues of the Tri1 N terminal (Fig. 4j-m, Extended Data Fig. 8b, d, f) . Truncating 20, 40 and 65 residues of the Tri1 N terminal, which removes one, two and three tripod arms, reduced virion production by 88.4%, 99.7% and to an undetectable level, respectively (Fig. 4j, k) . Furthermore, we observed Letter reSeArCH the accumulation of empty capsid-like particles in the nuclei of cells that lytically replicated the Tri1Δ N65 mutant virus (Fig. 4l, m ), in contrast to the observation with MCPΔ N40 mutant virus, in which lack of virion production was probably due to complete abolition of capsid assembly (Fig. 3k, l) . Although triplex has been proposed to incorporate three MCP subunits into an assembly unit for procapsid formation 25 , our mutagenesis results indicate that the Tri1 N-anchor is not required for triplex incorporation during capsid assembly, though it is essential for DNA containment in the C-capsids.
The hotspots of interactions revealed in the above structural and mutational analyses can be targeted for designing capsid assembly inhibitors. Current therapies against herpesvirus infections are based on nucleoside analogues that target viral genome replication, a process that bears some similarity to cellular DNA replication. These therapies therefore suffer from cytotoxicity and drug resistance 26 , which generates a need for potent non-nucleosidic antiviral compounds. Compounds that target capsid formation or stability are a potential option and have been actively pursued in research focusing on HIV and hepatitis B 27-30 ; owing to the absence of atomic structures for herpesvirus capsids, similar strategies have been hindered in herpes research. Our structure reveals an interaction hotspot that seems to offer a promising target for developing antiviral agents: the hydrophobic groove on the MCP surface, into which the SCP stem helix binds. We reason that a short polypeptide that mimics the SCP stem helix would compete with wild-type SCP for binding to MCP, interrupt the crosslinking and stabilizing effect of the SCP, and thereby inhibit KSHV lytic replication. To test this strategy, we constructed three polypeptides that contained the stem helix, the bridging helix or three tandem repeats of the stem helix (3SH ) (Fig. 2d ). When expressed in cells, 3SH polypeptides interacted with the MCPud in a similar way to wild-type SCP (Extended Data Fig. 5b, c) . Expression of stem helix or 3SH polypeptides in KSHV-replicating cells reduced virion production by 90% and 98.8%, respectively; expression of bridging helix polypeptides did not affect virion production (Fig. 2e) . Further experiments with 3SH polypeptides indicated that its inhibition of virion production is dose dependent (Fig. 2f) . Therefore, the SCP stem helix is a starting point or even a possible lead compound for the development of drugs targeting KSHV. If this SCP-mimicking polypeptide proves to be useful in Supplementary Information is available in the online version of the paper.
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MethODS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Sample preparation. Culture and purification of KSHV virions followed a previously described procedure 8, 21 . In brief, KSHV lytic replication was induced in an iSLK-puro cell line that harbours the KSHV-BAC16 plasmid 31, 32 . The tissue culture supernatant was collected and KSHV virions were pelleted by ultracentrifugation and purified by sucrose density gradient 9, 33 . An aliquot of 2.5 μ l purified virion sample was applied onto a Quantifoil R2/1 Cu grid, manually blotted with filter paper and plunge-frozen in liquid ethane. The large size (over 200 nm) of the KSHV virion and frequent contamination of even larger (up to 500 nm) virus-like vesicles in the density-gradient-purified sample (Extended Data Fig. 1a) presented a major challenge to obtaining an optimal cryo-EM grid that had both fully embedded particles and adequately thin ice for high-resolution cryo-EM imaging. Moreover, in order to collect enough data for high-resolution structure determination, the sample must have a 'perfect' concentration so that at least a few particles can be imaged within each micrograph but not be over-concentrated, which results in overlapping particles and thick ice. We experimented with more than 30 rounds of virus culture and purification, and screened hundreds of cryo-EM grids to obtain just two that were deemed adequate for high-resolution cryo-EM imaging. The best cryo-EM grids for KSHV virions we obtained were prepared by manual blotting with the filter paper parallel to the grid surface rather than with the commonly used Vitrobot, in which the filter paper blots the grid at an angle and the excess sample solution flows to the filter paper from one edge of the grid. Cryo-EM imaging and data preprocessing. Cryo-EM images were recorded in an FEI Titan Krios cryo-electron microscope. We collected 8,007 movies using Leginon 34 with a Gatan K2 Summit direct electron detector in super-resolution mode. Each movie consists of 26 frames, each of which has an exposure time of 500 ms. A dose rate of approximately 8 electrons per hardware pixel per second was set for exposure to facilitate electron counting in the camera. The pixel size in K2 super-resolution images at 14,000× nominal magnification was calibrated to be 1.03 Å per pixel. Thus, the accumulated dose for each movie was approximately 25 e − per Å 2 on the sample. All 26 frames in each movie were aligned and averaged for drift correction 35 . Defocus values were determined with CTFFIND3 36 to be in the range of − 1 μ m to -3 μ m. Particles were picked with Ethan 37 and then manually screened with the boxer program in EMAN 38 to keep only well-separated and artefact-free particles. A total of 44,343 particle images were boxed out from the micrographs with EMAN. 3D structure determination. The enormous size of 1,440× 1,440 pixels for individual particle image is too large or requires an unrealistic amount of computational resources to process with many popular cryo-EM software packages. To process the data, we modified and rebuilt our common-line based refinement program package (IMIRS 39, 40 ) and GPU-implemented reconstruction program (eLite3D 41 ), to expand data processing capacities. The original images were also binned 8× , 4× or 2× stepwise to speed up data processing.
Initial orientation and centre parameters for each particle were determined using data points in the very low resolution range (500-30 Å), without contrast transfer function correction. A phase-residue value was reported for each particle that directly measured the agreement of the cross common-lines between the cryo-EM image and the projected template. High phase-residue values typically result from incorrect identifications of the cross common-lines (that is, incorrect orientation assignment for that particle) or from low-quality particles (such as broken or contaminated particles). By sorting and grouping the particles with phase-residue values in steps of 0.4 and plotting the number of particles in each group, we found that there were two well-separated peaks of phase-residue distribution in the dataset (Extended Data Fig. 1b) . The number of particles in the high phase-residue peak constituted approximately 35% of the dataset. We checked a previous dataset (X.D. et al., unpublished data) of the KSHV virion that was recorded on photographic film and found that the high phase-residue peak constituted an even higher percentage (55%) of that dataset (Extended Data  Fig. 1c) , probably owing to a lower contrast of the film dataset in comparison with our current K2 super-resolution dataset. Because only low-resolution (and thus relatively less noisy) data points were used in the initial centre and orientation search, the high phase-residue particles should be treated as 'bad particles' and the low phase-residue ones as 'good particles' . The relatively high percentage of bad particles in the KSHV dataset compared to that in viral datasets we have previously worked on (for example, refs 42, 43) might be caused by relatively thick ice of the KSHV cryo-EM grid and, more probably, by the thick and pleomorphic tegument layer in the KSHV virion, which not only deteriorates the contrast of the cryo-EM images but also acts as a contaminant to the capsid projection, which interferes with centre and orientation searches for the capsid. As the refinement gradually proceeds to include more and more high-resolution data points, the phase residue of all particles would shift towards the 90° maximum. Conceivably, the phase residue of a good particle would shift faster than that of a bad particle, so the two well-separated peaks observed at the initial stage would gradually overlap with one another. Therefore, at a late stage of the refinement procedure, it would be difficult or even impossible to use a single phase-residue cutoff to select most of the good particles for 3D reconstruction. To prevent the bad particles from 'contaminating' the final reconstruction, we adopted a strategy in which bad particles were sorted out and thrown away after the initial step of centre and orientation search, and before the refinement procedure. A total of 29,100 high-quality particles in the first peak of phase-residue distribution, constituting approximately 65% of the entire dataset, were selected, divided into two random halves and separately subjected to iterative refinement. At the end of each iteration, a phase-residue cutoff was set to select the top approximately 85% of particles for reconstruction (Extended Data Fig. 1d) .
After convergence of refinement for both halves, a Fourier shell correlation (FSC) curve was calculated and the resolution was determined to be 4.2 Å on the basis of the gold-standard FSC = 0.143 criterion 44 . Then, the two halves of the dataset were combined and a total of 25,315 particles were used to calculate the final density map. A B-factor of − 200 Å 2 was applied to sharpen the density map for model building and structure analysis. Local averaging. There are 15 copies of hexon MCP or SCP (C1-C6, E1-E3 and P1-P6) and five copies of triplex (Ta-Te) in the asymmetric unit of the KSHV capsid. The quasi-equivalent copies of each kind are structurally similar and thus can be averaged to boost the signal-to-noise ratio of the density map, and to facilitate backbone tracing during atomic model building. By segmenting out cuboid density blocks encompassing each copy of MCP, SCP or triplex, and fitting them to each other in Chimera 45 , we identified that densities of MCP or SCP C1-C6 or triplexes Tb-Te have the best quality and are structurally least different among their kind. These aligned density blocks in each kind were averaged with the vop command in Chimera. Atomic model building. The local-averaged MCP, SCP or triplex density maps were fitted into the original map at one of the quasi-equivalent positions and both were used for ab initio modelling in Coot 46 . Generally, the local-averaged map has much improved main-chain densities that help to resolve ambiguities of backbone tracing; whereas the original map has better side chain densities that provide landmarks for amino acid registration. The crystallographic model of HSV-1 MCPud (RSCB Protein Data Bank (PDB) code: 1NO7) 20 fits into our KSHV density map and was therefore referred to when tracing backbone for the KSHV MCPud.
The first atomic model of MCP, SCP or triplex was refined using the real space refinement utility in Phenix 47 and then manually checked in Coot. This procedure was repeated several times until a satisfactory model was obtained. These first models of each kind were fitted into the original density map at other quasi-equivalent positions and manually adjusted in Coot for structural variations. For penton MCP, a majority of the tower region (including upper, channel and buttress domains) is noisy and broken in the sharpened map, and is therefore difficult to model ab initio. However, by low-pass filtering the density map to 6 Å resolution (so that the noisy penton tower could be visualized), and fitting a hexon MCP model into the penton density, we found that the tower regions of penton MCP and hexon MCP are structurally almost identical. In the floor region, where the two structures differ substantially, the penton density shows adequate quality for ab initio modelling. Therefore, the tower region of hexon MCP model is chimaerized with the ab initio model of the penton MCP floor region to synthesize the full model of penton MCP for presentation purposes.
In summary, we built atomic models for a total of 46 unique conformers of the four capsid proteins: 15 hexon MCP (amino acids 1-1,141, 1,164-1,376 ), 1 penton MCP (ab initio modelling of amino acids 47-409, 1,261-1,293 except for small flexible regions, and fitting of the remaining with hexon MCP model), 15 hexon SCP (amino acids 2-79), 5 Tri1 (amino acids 4-213, 217-331) and 10 Tri2 (amino acids 2-163, 174-305 of Tri2A; 2-196, 201-305 of Tri2B). As the last step, the refined atomic models of all individual conformers were combined and refined together in Phenix to resolve intermolecular clashes at the interface. Though not resolved at high resolution, the densities of five capsid-associated tegument complexes, which crown each penton, are visible when the map is lowpass filtered to approximately 6 Å resolution, suggesting their relative flexibility/ low occupancy 21 . This resolution was not sufficient to support model building for the capsid-associated tegument complexes. Construction of MCP-truncated or Tri1-truncated KSHV mutants. The KSHV-BAC16 plasmid was modified according to a previously described method 32, 48 . In brief, DNA fragments of KSHV ORF25 (MCP) or ORF62 (Tri1) with truncation of the defined amino acids were used to replace the wild-type sequence in the KSHV BAC by homogeneous recombination in Escherichia coli. Restriction patterns of the mutated KSHV BACs were verified by comparing them to that of the wild type to ensure overall genome integrity without gross changes. Fragments with the mutations in the middle were amplified from the plasmids by PCR, and sequenced to confirm that all mutations were correct. All mutant KSHV BACs were introduced into iSLK-puro cells, followed by selection with 1,200 μ g ml −1 hygromycin B, 1 μ g ml −1 puromycin and 250 μ g ml −1 G418 for one month to generate cell lines latently infected by a specific KSHV mutant virus. Titration of infectious KSHV virions. To determine the concentration of infectious KSHV virions released from iSLK-puro cells harbouring a wild-type, MCPtruncated or Tri1-truncated KSHV genome, cells were treated with 1 mM sodium butyrate plus 1 μ g ml −1 doxycycline for three days to induce KSHV lytic replication. Then, the supernatants were collected, centrifuged at 10,000g for 10 minutes at 4 °C to remove cellular debris, serially diluted in DMEM with 10% FBS and used to infect 293T cells in 96-well plates by spinoculation (3,000g for 1 h at 30 °C). Three days after infection, GFP-positive cell clusters containing two or more cells were counted under a fluorescence microscope to determine the titre of KSHV virions. Infectious units are expressed as the number of GFP-positive cell clusters in each well at a specific dilution of the viral stock. Measuring viral DNA replication and RNA expression by real-time PCR. Total DNA was isolated from cells replicating KSHV, and viral genome copy numbers were determined by real-time PCR using primers for ORF59, a gene essential for viral genome replication 49 . Total RNA was extracted from cells with a Purelink RNA mini kit (Thermo Fisher Scientific), treated with DNase I and reverse transcribed using SuperScript III reverse transcriptase (Thermo Fisher Scientific) and random hexamers. Real-time PCR was then performed with the following primers to detect the corresponding DNA or transcripts. GAPDH: 5′-TGCACCACCAACTGCTTAGC-3′ and 5′-GGCATGGACTGTGGTCAT GAG-3′; RTA: 5′-CACAAAAATGGCGCAAGATGA-3′ and 5′-TGGTAGAGTTGG GCCTTCAGTT-3′; ORF59: 5′-TTGGCACTCCAACGAAATATTAGAA-3′ and 5′-CGGGAACCTTTTGCGAAGA-3′; ORF57: 5′-TGGACATTATGAAGGGCATC CTA-3′ and 5′-CGGGTTCGGACAATTGCT-3′; ORF52: 5′-CTTACGATGGA AGACCTAACCG-3′ and 5′-ATCCCAGTGCTTTCCGAAG-3′; ORF25 (MCP): 5′-CGTATCCCCTGTTCTGCTATG-3′ and 5′-TTTTCCCGAGTTGACCCAG-3′; ORF62 (Tri1): 5′-TCGTTGGTTTATCTCCGTGTG-3′ and 5′-CAGCTGAATATAC TTGGTCCGG-3′ . Western blotting and antibodies. Proteins in SDS-PAGE sample buffer were heated at 95 °C, resolved by SDS-PAGE and then transferred onto PVDF membrane. Proteins were detected with antibodies against KSHV RTA (polyclonal antibody produced in rabbit), SCP (polyclonal antibody produced in rabbit 50 ), Tri1 (Thermo Fisher Scientific) or actin (Abcam). HRP-conjugated secondary antibodies were used and detection was performed with ECL (Amersham). Plastic embedding, ultrathin sectioning and conventional transmission electron microscopy. Cells induced for lytic replication of the wild-type, MCP-truncated or Tri1-truncated KSHV were collected after trypsin treatment and subjected to plastic embedding and transmission electron microscopy as previously described 8 .
In brief, cells were washed with PBS, fixed with 2% glutaraldehyde in PBS for 1 h, post-fixed in 1% OsO 4 for 1 h, stained en bloc in 2% uranyl acetate for 1 h, dehydrated in an ascending ethanol series and embedded using the Ultra Bed Low Viscosity Epoxy Kit (Electron Microscopy Sciences). Approximately 75-nm-thick sections were stained with saturated aqueous uranyl acetate and lead citrate, and examined with an FEI Tecnai F20 electron microscope. Co-immunoprecipitation assay to detect MCP-SCP binding. Coimmunoprecipitation experiments were performed as previously described 51 . In brief, 293T cells were transfected with SCP-Flag and Myc-MCPud (amino acids 478-1,033) expression plasmids and lysed at two days post-transfection with RIPA buffer (50 mM Tris-HCl pH 7.4, 0.5% NP-40, 150 mM NaCl, 1 mM EDTA and protease inhibitors). After pre-clearance with protein G-sepharose beads (GE Health) for 1 h at 4 °C, cell lysates were incubated with 1 μ g anti-Myc antibody for at least 4 h at 4 °C with constant agitation. Then, protein complexes were collected by incubating with protein G-sepharose beads for 1 h, and further washed five times with RIPA buffer. Proteins were eluted from beads with 60 μ l SDS-PAGE sample buffer and subjected to western blotting analysis using anti-Flag and antiMyc antibodies. Construction and test of SCP-mimicking polypeptides. The coding region for the SCP stem helix (amino acids 37-68) or bridging helix (amino acids 66-81) was amplified from KSHV-BAC16 plasmid by PCR, and the coding region for DsRed was amplified from pCMV-DsRed-Express plasmid (Clontech) by PCR. Stem helix or bridging helix fragments were linked to DsRed fragment by PCR reaction, and then cloned into the EcoRI site of pCMV-noHA vector 51 to generate SH-RED and BH-RED polypeptide expression plasmids, respectively. The DNA sequence for three tandem repeats of stem helix linked with Ser-Gln-Pro residues and C-terminal Flag-tag was synthesized de novo (Integrated DNA Technologies), and then cloned into the EcoRI site of pCMV-noHA vector to generate the 3SH polypeptide expression plasmid. Sequences of the PCR-amplified or synthesized fragments and their correct insertion in the plasmid were verified by sequencing. KSHV latently infected 293T cells were transfected with these polypeptide expression plasmids or the pCMV-DsRed-Express vector as control. At 16 h posttransfection, cells were treated with 0.5 mM sodium butyrate plus 25 ng ml −1 TPA to induce KSHV lytic replication. Three days later, the supernatants were collected for virion titration. Data availability. The cryo-EM density map and the atomic models have been deposited in the Electron Microscopy Data Bank and RCSB Protein Data Bank under accession numbers EMD-7047 and 6B43, respectively. All other data are available from the corresponding authors upon reasonable request.
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Extended Data Figure 1 | Cryo-EM imaging of KSHV particles and data processing strategy to minimize interference of the tegument layer. a, A cryo-EM micrograph. Images recorded with a Gatan K2 Summit direct electron detector show largely intact KSHV virions in our sample preparation. Naked capsids were only occasionally observed. The defocus value of this micrograph was − 1.3 μ m. b, Plot of phase-residue value distribution of particles after initial determination of orientation and centre parameters. Particles in the second peak with high phase-residue values are regarded as bad particles, for which the parameters were not correctly determined owing to the interference of the thick, pleomorphic tegument layer or the low quality of the particle. These particles were discarded and not included for following refinement to avoid their contaminating the reconstruction. c, Plot of phase-residue value distribution of our previous film dataset (X.D. et al., unpublished data) showing even more bad particles than those recorded in b, probably owing to decreased contrast of the film dataset compared to that of our current K2 dataset (b). d, Plot of phase-residue value distribution of particles after the final round of parameter refinement. There is only one peak representing the good particles, because the bad particles were discarded at the beginning of the refinement procedure. Moreover, only the top 85% of these good particles were selected for reconstruction. White lines denote the phase-residue value cutoff to select particles for refinement (b, c) or reconstruction (d). 
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
For cryoEM data acquisition, processing and modeling: Leginon, EMAN 1.9, CTFFIND3, IMIRS, eLite3D, UCSF Chimera, and Phenix are all open source software published and downloadable from internet.
For functional data analysis, Microsoft Excel was used.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All unique materials used are readily available from the authors.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). c. Report whether the cell lines were tested for mycoplasma contamination.
The cell lines were not tested for mycoplasma contamination.
d. If any of the cell lines used are listed in the database of commonly misidentified cell lines maintained by ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
